UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Teplizumab for treatment of type 1 diabetes (Protégé study): 1-year results from a randomised, placebo-controlled trial

The Lancet (British edition), 2011, Vol.378 (9790), p.487-497

2011

Volltextzugriff (PDF)

IL-10-dependent Tr1 cells attenuate astrocyte activation and ameliorate chronic central nervous system inflammation

Brain (London, England : 1878), 2016-07, Vol.139 (Pt 7), p.1939-1957

2016

Volltextzugriff (PDF)

Usefulness of Immunosuppression for Giant Cell Myocarditis

The American journal of cardiology, 2008-12, Vol.102 (11), p.1535-1539

2008

Volltextzugriff (PDF)

Oral Administration of OKT3 MAb to Patients with NASH, Promotes Regulatory T-cell Induction, and Alleviates Insulin Resistance: Results of a Phase IIa Blinded Placebo-Controlled Trial

Journal of clinical immunology, 2015-05, Vol.35 (4), p.399-407

2015

Volltextzugriff (PDF)

SIRPγ-CD47 Interaction Positively Regulates the Activation of Human T Cells in Situation of Chronic Stimulation

Frontiers in immunology, 2021-12, Vol.12, p.732530-732530

2021

Volltextzugriff (PDF)

Development and Evaluation of Tri-Functional Immunoliposomes for the Treatment of HER2 Positive Breast Cancer

Pharmaceutical research, 2018-05, Vol.35 (5), p.95-14, Article 95

2018

Volltextzugriff (PDF)

Anti-CD3 antibodies for type 1 diabetes: beyond expectations

The Lancet (British edition), 2011-08, Vol.378 (9790), p.459-460

Bach, Jean-François

2011

Volltextzugriff (PDF)

Oral Administration of OKT3 Monoclonal Antibody to Human Subjects Induces a Dose-Dependent Immunologic Effect in T Cells and Dendritic Cells

Journal of clinical immunology, 2010-01, Vol.30 (1), p.167-177

2010

Volltextzugriff (PDF)

Haploidentical allogeneic hematopoietic cell transplantation in adults using CD3/CD19 depletion and reduced intensity conditioning: An update

Blood cells, molecules, & diseases, 2008, Vol.40 (1), p.13-19

2008

Volltextzugriff (PDF)

The impact of mycophenolate mofetil dosing patterns on clinical outcome after renal transplantation

Clinical transplantation, 2003-06, Vol.17 (3), p.200-205

2003

Volltextzugriff (PDF)

Sirolimus as primary immunosuppression in liver transplantation is not associated with hepatic artery or wound complications

Liver transplantation, 2003-05, Vol.9 (5), p.463-468

2003

Volltextzugriff (PDF)

Induction therapy in lung transplantation: a prospective, controlled clinical trial comparing OKT3, anti-thymocyte globulin, and daclizumab

The Journal of heart and lung transplantation, 2001-12, Vol.20 (12), p.1282-1290

2001

Volltextzugriff (PDF)

Incidence of non-hodgkin lymphoma in kidney and heart transplant recipients

The Lancet (British edition), 1993-12, Vol.342 (8886), p.1514-1516

1993

Volltextzugriff (PDF)

Kidney transplantation from living-unrelated donors: comparison of outcome with living-related and cadaveric transplants under current immunosuppressive protocols

Urology (Ridgewood, N.J.), 2003-12, Vol.62 (6), p.1002-1006

2003

Volltextzugriff (PDF)

Muromonab-CD3 therapy for refractory rejections after liver transplantation: a single-center experience during two decades in Japan

Journal of hepato-biliary-pancreatic sciences, 2010-11, Vol.17 (6), p.885-891

2010

Volltextzugriff (PDF)

Delayed Onset of Cardiac Allograft Vasculopathy by Induction Therapy Using Anti-thymocyte Globulin

The Journal of heart and lung transplantation, 2008-06, Vol.27 (6), p.603-609

2008

Volltextzugriff (PDF)

Long-term stability of T-cell activation and transduction components critical to the processing of clinical batches of gene-engineered T cells

Cytotherapy (Oxford, England), 2013-05, Vol.15 (5), p.620-626

2013

Volltextzugriff (PDF)

Newly Defined Clinical Features and Treatment Experience of Seventh Day Syndrome Following Living Donor Liver Transplantation

Transplantation proceedings, 2012-03, Vol.44 (2), p.494-499

2012

Volltextzugriff (PDF)

Early discontinuation of steroids is safe and effective in pediatric kidney transplant recipients

Pediatric transplantation, 2005-08, Vol.9 (4), p.456-463

2005

Volltextzugriff (PDF)

MONOCLONAL ANTIBODIES AS TARGETING AND THERAPEUTIC AGENTS: PROSPECTS FOR LIVER TRANSPLANTATION, HEPATITIS AND HEPATOCELLULAR CARCINOMA

Clinical and experimental pharmacology & physiology, 2006-05, Vol.33 (5‐6), p.482-488

2006

Volltextzugriff (PDF)

Clinical study of single-dose of recombinant humanized anti-CD3 monoclonal antibody injection in kidney transplant recipients

Zhong hua yi xue za zhi, 2011-03, Vol.91 (8), p.516-519

2011

Volltextzugriff (PDF)

Induction treatment with monoclonal antibodies for heart transplantation

Transplantation reviews (Philadelphia, Pa.), 2011, Vol.25 (1), p.21-26

2011

Volltextzugriff (PDF)

OKT3 muromonab as second-line and subsequent treatment in recipients of stem cell allografts with steroid-resistant acute graft-versus-host disease

Bone marrow transplantation (Basingstoke), 2005-11, Vol.36 (9), p.831-837

2005

Volltextzugriff (PDF)

OKT3 neurotoxicity presenting as akinetic mutism

Transplantation, 2003-04, Vol.75 (7), p.1058-1060

2003

Volltextzugriff (PDF)

A randomized clinical trial of induction therapy with OKT3 in kidney transplantation

Transplantation, 1993-01, Vol.55 (1), p.44-50

1993

Volltextzugriff (PDF)

1 – 25 von 295

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(266)
Mit Volltextzugriff
(149)

Publikationsform

Artikel
(295)

Sprache

4 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Humans
(283)
Science & Technology
(236)
Life Sciences & Biomedicine
(234)
Biological And Medical Sciences
(174)
Male
(167)
Medical Sciences
(166)
Female
(165)
Muromonab-Cd3 - Administration & Dosage
(161)
Transplantation
(145)
Adult
(140)
Surgery
(137)
Middle Aged
(121)
Muromonab-Cd3 - Therapeutic Use
(120)
Immunology
(105)
Pharmacology. Drug Treatments
(100)
Immunosuppressive Agents - Administration & Dosage
(95)
Muromonab-Cd3 - Adverse Effects
(84)
Immunosuppressive Agents - Therapeutic Use
(78)
Graft Rejection - Prevention & Control
(71)
Immunomodulators
(69)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Teplizumab for treatment of type 1 diabetes (Protégé study): 1-year results from a randomised, placebo-controlled trial

IL-10-dependent Tr1 cells attenuate astrocyte activation and ameliorate chronic central nervous system inflammation

Usefulness of Immunosuppression for Giant Cell Myocarditis

Oral Administration of OKT3 MAb to Patients with NASH, Promotes Regulatory T-cell Induction, and Alleviates Insulin Resistance: Results of a Phase IIa Blinded Placebo-Controlled Trial

SIRPγ-CD47 Interaction Positively Regulates the Activation of Human T Cells in Situation of Chronic Stimulation

Development and Evaluation of Tri-Functional Immunoliposomes for the Treatment of HER2 Positive Breast Cancer

Anti-CD3 antibodies for type 1 diabetes: beyond expectations

Oral Administration of OKT3 Monoclonal Antibody to Human Subjects Induces a Dose-Dependent Immunologic Effect in T Cells and Dendritic Cells

Haploidentical allogeneic hematopoietic cell transplantation in adults using CD3/CD19 depletion and reduced intensity conditioning: An update

The impact of mycophenolate mofetil dosing patterns on clinical outcome after renal transplantation

Sirolimus as primary immunosuppression in liver transplantation is not associated with hepatic artery or wound complications

Induction therapy in lung transplantation: a prospective, controlled clinical trial comparing OKT3, anti-thymocyte globulin, and daclizumab

Incidence of non-hodgkin lymphoma in kidney and heart transplant recipients

Kidney transplantation from living-unrelated donors: comparison of outcome with living-related and cadaveric transplants under current immunosuppressive protocols

Muromonab-CD3 therapy for refractory rejections after liver transplantation: a single-center experience during two decades in Japan

Delayed Onset of Cardiac Allograft Vasculopathy by Induction Therapy Using Anti-thymocyte Globulin

Long-term stability of T-cell activation and transduction components critical to the processing of clinical batches of gene-engineered T cells

Newly Defined Clinical Features and Treatment Experience of Seventh Day Syndrome Following Living Donor Liver Transplantation

Early discontinuation of steroids is safe and effective in pediatric kidney transplant recipients

MONOCLONAL ANTIBODIES AS TARGETING AND THERAPEUTIC AGENTS: PROSPECTS FOR LIVER TRANSPLANTATION, HEPATITIS AND HEPATOCELLULAR CARCINOMA

Clinical study of single-dose of recombinant humanized anti-CD3 monoclonal antibody injection in kidney transplant recipients

Induction treatment with monoclonal antibodies for heart transplantation

OKT3 muromonab as second-line and subsequent treatment in recipients of stem cell allografts with steroid-resistant acute graft-versus-host disease

OKT3 neurotoxicity presenting as akinetic mutism

A randomized clinical trial of induction therapy with OKT3 in kidney transplantation

Suchergebnisse filtern